Targeting Inflammation in Treatment Resistant Depression
Research published in this month’s Archives of General Psychiatry evaluated the use of a monoclonal antibody (mAb) against tumor necrosis factor (TNF) alpha for treatment resistant depression.
Researchers at Emory University studied whether blocking inflammation would be a useful treatment …